Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Kuehn Law Encourages CHRD, AVRO, KAMN, and CTLT Investors to Contact Law Firm

CTLT, CHRD

NEW YORK, Feb. 27, 2024/PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating potential claims related to the below-listed proposed mergers. Kuehn Law may seek additional disclosures or other relief on behalf of the shareholders of these companies.

Kuehn Law, PLLC (PRNewsfoto/Kuehn Law, PLLC)

Kuehn Law is investigating whether the Boards of the below companies 1) acted to maximize shareholder value, 2) failed to disclose material information, and 3) conducted a fair process:

  • Chord Energy Corporation (Nasdaq: CHRD)click to participate
    Chord Energy has agreed to merge with Enerplus Corporation. Under the agreement, shareholders of Enerplus will receive 0.10125 shares of Chord common stock and $1.84 per share in cash.
  • AVROBIO, Inc. (Nasdaq: AVRO)click to participate
    AVROBIO has agreed to merge with Tectonic Therapeutic. Under the agreement, current shareholders of AVROBIO are anticipated to hold about 22.3% of the merged entity.
  • Kaman Corp. (NYSE: KAMN)click to participate
    Kaman has reached a deal to be quired by Arcline Investment Management, L.P. In this deal, each Kaman shareholder will be paid $46.00 per share in a cash transaction.
  • Catalent, Inc. (NYSE: CTLT)click to participate
    Novo Holdings has agreed to purchase Catalent. In accordance with the merger agreement, Catalent shareholders will receive $63.50 per share in cash.

Why Your Participation Matters:

As a shareholder your voice matters, and by getting involved, you contribute to the integrity and fairness of the financial markets.Your investment. Your voice. Your future.

How to Get Involved:

Kuehn Law is dedicated to safeguarding shareholder interests. Concerned shareholders are encouraged to contact Justin Kuehn, Esq., at justin@kuehn.law or call(833) 672-0814. Kuehn Law covers all case costs and does not charge its investor clients. Shareholders are advised to act promptly, as legal rights may be time-sensitive. For additional information, please visit Merger Litigation - Kuehn Law.

Attorney advertising. Prior results do not guarantee similar outcomes.

Contacts:
Kuehn Law, PLLC
Justin Kuehn, Esq.
53 Hill Street, Suite 605
Southampton, NY 11968
justin@kuehn.law
(833) 672-0814

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/kuehn-law-encourages-chrd-avro-kamn-and-ctlt-investors-to-contact-law-firm-302072856.html

SOURCE Kuehn Law, PLLC



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today